, Volume 4, Issue 3, pp 146-151

A double-blind clinical trial of a β2-adrenergic agonist in stress incontinence

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


A multicenter double-blind placebo-controlled trial was performed on aβ 2-adrenergic agonist, clenbuterol, in 165 women with stress incontinence. Clenbuterol remarkably improved the stress incontinence, and urodynamically the drug was found to increase the maximal urethral closure pressure. Some side effects were noted, but they were not serious. The results of this trial showed clenbuterol to be a promising drug for the treatment of stress incontinence.